Retatrutide – 30mg Product Information
Retatrutide 30mg — Research Overview Retatrutide 30mg is a next-generation multi-agonist peptide investigated in metabolic research for its activity at GLP-1, GIP, and glucagon receptors. In laboratory settings, this unique receptor profile makes it a valuable tool for studying complex energy-regulation pathways, insulin sensitivity and lipid metabolism. This compound is supplied by ReGen-X exclusively for scientific and laboratory research. Mechanism of Action (Research Context) In controlled research environments, retatrutide has been shown to interact with three key metabolic signalling pathways: GLP-1 receptor activity — associated with appetite signalling and glucose regulation GIP receptor activity — involved in insulin and fat metabolism Glucagon receptor activity — linked to energy expenditure and lipid mobilisation This triple-pathway engagement makes retatrutide of particular interest for metabolic and endocrine research models studying obesity, insulin resistance and energy homeostasis. Research Summary Retatrutide has been evaluated in pre-clinical and clinical research models for its potential role in: Metabolic rate modulation Glucose and insulin signalling pathways Fat oxidation and lipid transport Appetite and energy balance Browse our full range of Metabolic & GLP-1 research compounds. Product Specifications Compound: Retatrutide 30mg Quantity: 30mg Form: Lyophilised research peptide Included: 3ml bacteriostatic water (for laboratory reconstitution only) Storage: Refrigerated per laboratory standards Important Research Use Notice This product is sold strictly for laboratory and scientific research use only. It is not a medicine, not a supplement, and not approved for human or veterinary use. No medical, therapeutic, or health claims are made or implied.
